
Browsing restrictions can be lifted for a fee.
-16.05%
Cdt equity inc.
0.05%
Avg of Sector
-0.31%
S&P500

Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2026Q1 | ||||
| 2026Q2 | ||||
| 2026Q3 | ||||
| 2026Q4 | ||||
| 2027Q1 |
Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Cdt equity inc. (CDTTW) covers the period of 2025Q1 and was published on 2025/03/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CDTTW's short-term business performance and financial health. For the latest updates on CDTTW's earnings releases, visit this page regularly.
According to the latest financial report, Cdt equity inc. (CDTTW) reported an Operating Profit of -4.01M with an Operating Margin of -0.64% this period, representing a decline of 35.67% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, Cdt equity inc. (CDTTW) announced revenue of 624.86M, with a Year-Over-Year growth rate of 16.65%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, Cdt equity inc. (CDTTW) held Total Cash and Cash Equivalents of 3.33M, accounting for 0.42 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, Cdt equity inc. (CDTTW) did not achieve the “three margins increasing” benchmark, with a gross margin of 100%%, operating margin of -0.53%%, and net margin of -0.36%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CDTTW's profit trajectory and future growth potential.
According to the past four quarterly reports, Cdt equity inc. (CDTTW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.29. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
Cdt equity inc. (CDTTW)'s Free Cash Flow (FCF) for the period is -24.76M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 6.94% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
The latest valuation data shows Cdt equity inc. (CDTTW) has a Price-To-Earnings (PE) ratio of -29.01 and a Price/Earnings-To-Growth (PEG) ratio of 0.15. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.